MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

Status

Terminated

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00543010

Enrollment

247

Registered

2007-10-12

Start date

2002-11-30

Completion date

2003-11-30

Last updated

2015-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Interventions

DRUGMK0767

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

21 Years to 80 Years

Healthy volunteers

Inclusion criteria

* You are taking at least one medication for high blood sugar * Age 21 to 80

Exclusion criteria

* History of Type 1 Diabetes Mellitus * Currently on estrogen replacement therapy regimen * Currently on a weight loss program with ongoing weight loss or taking medications for weight loss * Having surgery 30 days before starting the study * Have taken any other investigational drug in the past 90 days * Have Hepatitis B or C * Active liver or gallbladder disease

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026